NDC 70518-4472-01 - Methocarbamol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4472
- Requested NDC
- 70518-4472-01
- Package NDCs from labels
- 70518-4472-0, 70518-4472-1, 70518-4472-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-09-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methocarbamol Tablets, USP | REMEDYREPACK INC. | 2026-09-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4472-0 | Methocarbamol | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 1 | |
| 70518-4472-1 | Methocarbamol | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stye | POLYVINYL ALCOHOL AND POVIDONE | Medtech Products Inc. | 60c11d3d-df20-4d1c-b425-49a84fecea30 | 2025-10-23 | Warnings | FZ989GH94E |
| iVIZIA Dry Eye | POVIDONE | Thea Pharma Inc. | 1ef73cb1-da48-a713-e063-6294a90afa9d | 2025-10-20 | Warnings | FZ989GH94E |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | 9aed8304-fa4e-49d6-bd81-fcb3e4cc6173 | 2025-10-16 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | PHOENIX RX LLC | 414b2fe0-fa2b-2b18-e063-6394a90ab2b9 | 2025-10-16 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | ff55df39-e314-4120-8fab-3757cbe5a872 | 2025-10-16 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | 069045f1-d699-41d0-b674-cdb71cd5fbd0 | 2025-10-15 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | f7ab7f11-9b5a-4d3a-a8fc-eee55b1fc006 | 2025-10-13 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | fdea0332-1ad8-40ef-8cb9-b3c46588155d | 2025-10-13 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Sagent Pharmaceuticals | 01e7e2c7-49eb-4afb-a496-f2bd901622e9 | 2025-09-29 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Solco Healthcare LLC | 32863f21-30ff-4a8b-a2e6-8ab14a37af0d | 2025-09-25 | Warnings, Adverse reactions | ANDA086988 43547-226 197944 197943 2786f72e-0a33-4258-89a9-693ebcfd19da 32863f21-30ff-4a8b-a2e6-8ab14a37af0d 125OD7737X |
| Eyes Irritation Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | CARDINAL HEALTH 110, LLC. DBA LEADER | bd2608c6-ffdf-352a-e053-2995a90a26a8 | 2025-09-12 | Warnings | FZ989GH94E |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | Bryant Ranch Prepack | dfb0e2ee-fd87-4100-9d44-f7a091e73a6c | 2025-09-12 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PHOENIX RX LLC | 3b199152-bafc-e14a-e063-6394a90ab283 | 2025-07-29 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | f07c0a35-fb5d-43a1-a33e-d6a51a5fcd77 | 2025-07-23 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | 5f746f0f-e884-46d9-a104-529293b0fb90 | 2025-07-23 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | ff572473-90e3-4f3b-a40e-8b97b86d327b | 2025-07-16 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | fe872a3a-fb14-4a0a-b9e4-c9f1885b4978 | 2025-06-18 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | Granulation Technology, Inc. | 70c5342c-9597-4fe6-863c-f8ae4adc063a | 2025-06-10 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Golden State Medical Supply, Inc. | c67d3e2b-92cd-1b97-e053-2a95a90af36f | 2025-06-10 | Warnings, Adverse reactions | ANDA086988 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | 9357672f-5d4d-40f5-a304-e0c34e174dc3 | 2025-06-09 | Warnings, Adverse reactions | 197943 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.